Bariatric Surgery: An honest audit
Sleeve gastrectomy or Roux-en-Y gastric bypass — surgical weight-loss intervention
8/10
Sustainability
10/10
Short term
8/10
Long term
Three numbers, one rubric
Category
Surgical
Typical cost
No direct cost
First visible change
~14 days
Evidence rating
Strong evidence
Studies cited
2
How to read these scores
Sustainability
Weighted heaviest. Adherence predicts outcome more reliably than macro split, so an approach nobody can keep scores low here even when the trial data looks good.
Short-term effect
A high number here alone means very little. Water and glycogen move fast, and almost every restrictive protocol looks impressive at week four.
Long-term effect
Where short-term and long-term diverge sharply, you are usually looking at a regain mechanism built into the design — not a willpower failure.
What it promises — and how it says it works
The claim
What it claims
Bariatric surgery (sleeve gastrectomy, gastric bypass, gastric band) produces durable, large-magnitude weight loss (25-35% of total body weight at 1-2 years), with frequent type-2 diabetes remission and cardiovascular benefit.
The mechanism
How it is supposed to work
Sleeve gastrectomy reduces stomach volume to ~25% of original, restricting intake and altering gut hormones (ghrelin drops, GLP-1 rises). Roux-en-Y bypass adds malabsorption and significant gut-hormone changes. Both produce sustained appetite reduction and weight loss that's largely metabolic, not purely restrictive.
What the research actually shows
STAMPEDE¹, SOS Study, and decades of bariatric literature show bariatric surgery is the most durable and effective intervention for severe obesity. T2D remission rates exceed 60% at 1-2 years. Cardiovascular event reduction is substantial. All-cause mortality is reduced over 10-20 year follow-up.¹²
Footnote numbers link to the full reference list at the foot of this page.
Evidence rating
Strong evidence
Describes the quality and quantity of the peer-reviewed literature — trial count, duration, sample size and replication — not our opinion of the approach.
Early loss is not evidence. Glycogen carries roughly three grams of water per gram, so the first pounds on almost any restrictive protocol are largely water. What matters is what is still there at twelve and twenty-four months.
Right person, wrong person
Almost nothing on this site is universally good or universally useless. The useful question is which body, kitchen and calendar an approach was built for.
Worth a trial
Who it works for
Adults with BMI ≥40 (or ≥35 with significant comorbidity) who haven't responded to lifestyle and pharmacological intervention. Adults willing to commit to lifelong nutritional changes and supplementation. Adults with severe metabolic disease where the surgery's risk-benefit clearly favours intervention.
Look elsewhere
Who it fails
Adults with BMI <35 without severe comorbidity (the surgical risk doesn't justify intervention). Adults unwilling to commit to lifelong follow-up, supplementation, and dietary change. Adults with severe untreated psychiatric conditions (esp. eating-disorder history).
Bariatric surgery is the most effective long-term intervention for severe obesity in the medical literature. It's not for everyone, and the surgical risks and lifetime nutritional follow-up are real. For adults with BMI ≥40 or significant comorbidity who haven't responded to other interventions, it's an evidence-based, often life-saving option that we don't dismiss. The cultural reluctance to recommend bariatric surgery to qualifying patients is a public-health failure given the strength of the evidence.
Written against the rubric, not against a sponsor. Individual response varies and no outcome is guaranteed.
What to do instead
If you qualify for bariatric surgery, get a serious surgical consultation. If you don't qualify but have substantial weight to lose, GLP-1 drugs plus lifestyle intervention is the next-best evidence-based path.
Not sure which fits
Get a read on your profile
Fifteen questions, roughly two minutes, no email wall on the result. Returns a starter protocol matched to your metabolic situation.
Take the assessmentStraight answers
Bariatric Surgery, without the spin
We score Bariatric Surgery 8/10 for sustainability, 10/10 for short-term effect and 8/10 for long-term effect. A gap between the short-term and long-term numbers is the single most common pattern in this index — an approach can move the scale quickly and still leave almost nothing behind eighteen months later.
Sustainability is weighted heaviest for a reason: across head-to-head trials, adherence predicts outcome more reliably than which named diet you picked. A protocol you abandon in week six did nothing at all.
Can you still be doing this in month twelve?
First 12 weeks in controlled trials
What survives at 12–24 months
Educational summaries of published research. Individual response varies and no outcome is guaranteed.
References
- 01Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011). Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. PubMed 21656330
- 02Lean MEJ et al. (2018). Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. The Lancet. PubMed 29221645
Did Bariatric Surgery not work for you?
That is the rule rather than the exception, and it is usually a design problem in the protocol rather than a character problem in you. The assessment reads your situation and points you at the approach the research supports for that profile.
- Free, with no email wall on the result
- Fifteen questions, roughly two minutes
- Returns a starter protocol matched to your profile
- Every recommendation links back to its research
Educational only, not medical advice. This audit summarises published research and is not a diagnosis, a prescription, or a treatment plan. Consult your physician before major dietary changes or altering prescribed medication. These statements have not been evaluated by the Food and Drug Administration. Individual results vary; no outcome is guaranteed.